BioSpace News Archive

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced that the Company will participate in a fireside chat at the Goldman Sachs 41st Annual Global Healthcare Conference on Wednesday, June 10, 2020 at 8:50 a.m. ET. A live webcast of the conference ca

IQ4I Research & Consultancy published a new report on “Infectious Disease Diagnostics Global Market – Forecast To 2026".

Dalrada Financial Corp. (OTC Pink: DFCO) is pleased to update its shareholders on the continued growth of its Technology Company, Prakat Solutions Inc. (Prakat).

Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today announced the following publications in peer-reviewed journals. The publication titled “Intravenous Tramadol is Effective in the Management of Postoperative Pain Following Abdominoplasty: A Three-Arm Randomized Placebo- and Active-Controlled Trial” has been published in Drugs in R&D and can be acc

Owens & Minor, Inc. (NYSE: OMI) (the “Company”) today announced that it has commenced offers to purchase for cash (collectively, the “Tender Offers” and each a “Tender Offer”) its outstanding senior notes listed in the table below for a maximum aggregate purchase price, excluding accrued interest, of up to $240,000,000 (the “Maximum Aggregate Purchase Price”) and, with respect to the 2021 Notes, a Consent Solicitation (

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE ( Conformité Européenne ) Mark for a one-month dual antiplatelet therapy (DAPT) indication for high bleeding risk (HBR) patients implanted with the Resolute Onyx™ Drug-Eluting Stent (DES). For HBR patients, whose bleeding risk may be increased by taking longer DAPT regimens (a combination of aspirin and anti-clotting medication), this new, first-of-it

Seeking to address estimates that more than a third of COVID-19 deaths nationally have occurred in nursing homes and long-term care facilities—more than 38,000 – the American Medical Directors Association published recommendations for reducing the spread of the pandemic virus among residents and staff.

Celerion announced today the expansion of specialized high-resolution mass spectrometry (HR-MS) profiling capabilities demonstrating their commitment to further assisting sponsors in meeting the regulatory requirements to characterize and quantify drug metabolites and their potential for impacting drug effect as part of the process to becoming an approved therapeutic product. Celerion has created a compelling bioanalytical

Retractable Technologies, Inc. (NYSE American: RVP) (the “Company”) today announced that, due to the public health impact of the coronavirus (COVID-19) pandemic, and related health and travel concerns, the adjourned 2020 annual meeting of shareholders of Retractable Technologies, Inc. (the “Annual Meeting”) has been changed to a virtual-only format via live webcast. As previously announced, the Annual Meeting will be he

Apotex is expanding the previously announced Retail Level recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg that was initiated on May 29, 2020 to Consumer Level.